Medical Equipment

Global Ovarian Cancer Diagnostics Market Valuation and Growth Prospects: $3.88 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the ovarian cancer diagnostics market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Ovarian Cancer Diagnostics Market Size?

The ovarian cancer diagnostics market size has experienced significant expansion recently. This market is projected to expand from $2.74 billion in 2024 to $2.9 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.7%. Historically, this expansion can be linked to several factors, including increased biomarker discovery and validation, wider adoption of transvaginal ultrasound, heightened awareness of BRCA gene mutations, ongoing research into tumor markers, and the implementation of screening programs and guidelines.

The ovarian cancer diagnostics market size is projected to experience strong growth in the coming years. It is expected to expand to $3.88 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.6%. This anticipated growth during the forecast period is attributed to initiatives for early detection, a rising incidence of ovarian cancer, the incorporation of artificial intelligence (AI), personalized medicine approaches, the introduction of novel biomarkers, and genomic and proteomic profiling. Prominent trends for the forecast period include biosensor technologies for early detection, the integration of digital pathology, advancements in imaging modalities, improved imaging technologies, and progress in pathology techniques.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12022&type=smp

What Core Market Drivers Are Expanding The Ovarian Cancer Diagnostics Industry?

The anticipated increase in the occurrence of ovarian cancer is expected to fuel the growth of the ovarian cancer diagnostics market. Ovarian cancer is a malignant tumor that originates in the ovaries, the female reproductive organs responsible for producing eggs and hormones. This rise has been influenced by factors such as increased longevity, delayed childbearing, and lifestyle modifications. Ovarian cancer diagnostics are instrumental in reducing the prevalence of ovarian cancer by facilitating early detection and intervention, which allows for timely treatment and better outcomes. For instance, in 2022, the World Ovarian Cancer, a Canada-based organization dedicated to raising awareness for women affected by ovarian cancer globally, projected that by 2050, the global incidence of ovarian cancer among women is expected to increase by more than 55%, reaching approximately 503,448 cases. Additionally, the annual death toll from ovarian cancer is forecast to rise to 350,956, marking an almost 70% increase compared to 2022. Therefore, the growing prevalence of ovarian cancer is a significant driver for the expansion of the ovarian cancer diagnosis market.

What Segment Insights Are Highlighted In The Ovarian Cancer Diagnostics Market Report?

The ovarian cancer diagnosticsmarket covered in this report is segmented –

1) By Product Type: Instruments, Kits, Reagents

2) By Diagnosis Type: Biopsy, Blood Test, Imaging, Other Diagnosis Types

3) By Cancer Type: Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor, Other Cancer Types

4) By End User: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes

Subsegments:

1) By Instruments: Imaging Systems, Biopsy Devices, Molecular Diagnostic Instruments

2) By Kits: Diagnostic Test Kits, Screening Kits

3) By Reagents: Antibodies, Enzymes, Assay Reagents

Which Notable Trends Are Transforming The Ovarian Cancer Diagnostics Market Outlook?

Advanced diagnostic technology is emerging as a significant trend in the ovarian cancer diagnostics market. Companies operating within the ovarian cancer diagnostic sector are adopting advanced diagnostic technologies to maintain their standing in the market. For instance, in November 2022, Hoffmann-La Roche AG, a Switzerland-based pharmaceutical and healthcare company, secured FDA approval for the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay. This marks the first (immunohistochemistry) IHC-based companion diagnostic test kit developed for identifying ovarian cancer patients eligible for ELAHERE, a prescription medication for ovarian cancer. This test is precisely engineered to yield critical insights and detailed clinical information regarding the ovarian cancer condition, which aids in achieving improved disease management and patient outcomes.

Which Firms Are Driving Innovation Within The Ovarian Cancer Diagnostics Market?

Major companies operating in the ovarian cancer diagnostics market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Bio-rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., ArcherDX Inc., Invitae Corporation, Guardant Health, Luminex Corporation, NanoString Technologies Inc., Siemens Healthcare Private Limited, Menarini Silicon Biosystems S.p.A., Precipio Inc., Angle plc

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ovarian-cancer-diagnostics-global-market-report

What Regional Trends Are Shaping Growth In The Ovarian Cancer Diagnostics Market?

North America was the largest region in the ovarian cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovarian cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12022&type=smp

Browse Through More Reports Similar to the Global Ovarian Cancer Diagnostics Market 2025, By The Business Research Company

Molecular Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Microbiology Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

Medical Equipment Maintenance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-equipment-maintenance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795